These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19648670)

  • 21. Effect of four medications associated with gastrointestinal motility on Oddi sphincter in the rabbit.
    Li C; Qian W; Hou X
    Pancreatology; 2009; 9(5):615-20. PubMed ID: 19657216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastroprokinetic effect of a new benzamide derivative itopride and its action mechanisms in conscious dogs.
    Iwanaga Y; Miyashita N; Saito T; Morikawa K; Itoh Z
    Jpn J Pharmacol; 1996 Jun; 71(2):129-37. PubMed ID: 8835639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azaadamantane benzamide 5-HT4 agonists: gastrointestinal prokinetic SC-54750.
    Becker DP; Flynn DL; Shone RL; Gullikson G
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5509-12. PubMed ID: 15482914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 5-HT4 agonist, mosapride, enhances intrinsic rectorectal and rectoanal reflexes after removal of extrinsic nerves in guinea pigs.
    Kojima Y; Nakagawa T; Katsui R; Fujii H; Nakajima Y; Takaki M
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G351-60. PubMed ID: 15817810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals.
    Yoshida N; Omoya H; Kato S; Ito T
    Arzneimittelforschung; 1993 Oct; 43(10):1078-83. PubMed ID: 8267674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of mosapride on ruminal motility in cattle.
    Arai S; Haritani M; Sawada H; Kimura K
    J Vet Med Sci; 2019 Jul; 81(7):1017-1020. PubMed ID: 31155551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of prokinetic agents in improving bowel preparation for colonoscopy.
    Mishima Y; Amano Y; Okita K; Takahashi Y; Moriyama N; Ishimura N; Furuta K; Ishihara S; Adachi K; Kinoshita Y
    Digestion; 2008; 77(3-4):166-72. PubMed ID: 18577886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.
    Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Nishi N; Chayama K; Haruma K
    J Gastroenterol Hepatol; 2007 Mar; 22(3):304-10. PubMed ID: 17295758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of new gastro-intestinal prokinetic (ENGIP-II) study.
    Walwaikar PP; Kulkarni SS; Bargaje RS
    J Indian Med Assoc; 2005 Dec; 103(12):708-9. PubMed ID: 16821670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of mosapride citrate, metoclopramide hydrochloride, lidocaine hydrochloride, and cisapride citrate on equine gastric emptying, small intestinal and caecal motility.
    Okamura K; Sasaki N; Yamada M; Yamada H; Inokuma H
    Res Vet Sci; 2009 Apr; 86(2):302-8. PubMed ID: 18723200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of mosapride on motility of the small intestine and caecum in normal horses after jejunocaecostomy.
    Okamura K; Sasaki N; Kikuchi T; Murata A; Lee I; Yamada H; Inokuma H
    J Vet Sci; 2009 Jun; 10(2):157-60. PubMed ID: 19461212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The rodent model of impaired gastric motility induced by allyl isothiocyanate, a pungent ingredient of wasabi, to evaluate therapeutic agents for functional dyspepsia.
    Hashimoto K; Tashima K; Imai T; Matsumoto K; Horie S
    J Pharmacol Sci; 2021 Jan; 145(1):122-129. PubMed ID: 33357770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of HSR-803 on gastrointestinal motility].
    Iwanaga H; Miyashita N; Kondo Y; Mizumoto A; Ito A
    Nihon Heikatsukin Gakkai Zasshi; 1989 Dec; 25(6):313-5. PubMed ID: 2702276
    [No Abstract]   [Full Text] [Related]  

  • 34. Effectiveness of prokinetic agents against diseases external to the gastrointestinal tract.
    Hiyama T; Yoshihara M; Tanaka S; Haruma K; Chayama K
    J Gastroenterol Hepatol; 2009 Apr; 24(4):537-46. PubMed ID: 19220673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human antroduodenal motility, pyloric closure, and domperidone.
    Eyre-Brook IA; Smallwood R; Johnson AG
    Scand J Gastroenterol Suppl; 1984; 92():4-7. PubMed ID: 6588533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of the current status of prokinetic agents in gastroenterology.
    McCallum RW
    Am J Gastroenterol; 1985 Dec; 80(12):1008-16. PubMed ID: 4072997
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis and biological activity of 4-amino-5-chloro-2-ethoxy-3-hydroxybenzamides, metabolites of a new gastroprokinetic agent, mosapride.
    Kato S; Morie T; Yoshida N
    Chem Pharm Bull (Tokyo); 1996 Aug; 44(8):1484-92. PubMed ID: 8795267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ranitidine Can Potentiate The Prokinetic Effect Of Itopride At Low Doses- An In Vitro Study.
    Butt AI; Khan BT; Khan A; Khan QU
    J Ayub Med Coll Abbottabad; 2017; 29(4):554-558. PubMed ID: 29330976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of dopamine D2 receptor antagonists on gastrointestinal motility].
    Mizumoto A; Ito A
    Nihon Heikatsukin Gakkai Zasshi; 1990 Apr; 26(2):65-9. PubMed ID: 2273688
    [No Abstract]   [Full Text] [Related]  

  • 40. The prokinetic effect of mosapride citrate on horse gastric emptying rates.
    Okamura K; Sasaki N; Fukunaka M; Yamada H; Inokuma H
    J Vet Med Sci; 2008 Jun; 70(6):627-8. PubMed ID: 18628607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.